J M Perel

2.4k total citations
39 papers, 1.8k citations indexed

About

J M Perel is a scholar working on Pharmacology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, J M Perel has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 11 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in J M Perel's work include Treatment of Major Depression (15 papers), Mental Health Research Topics (5 papers) and Metabolism and Genetic Disorders (4 papers). J M Perel is often cited by papers focused on Treatment of Major Depression (15 papers), Mental Health Research Topics (5 papers) and Metabolism and Genetic Disorders (4 papers). J M Perel collaborates with scholars based in United States and Slovenia. J M Perel's co-authors include P H Soloff, Peter G. Dayton, Katherine L. Wisner, Robert L. Findling, M Mavissakalian, Charles F. Reynolds, Robert S. Dealy, Bruce G. Pollock, Zafar H. Israili and Duane G. Spiker and has published in prestigious journals such as Circulation, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

J M Perel

39 papers receiving 1.6k citations

Peers

J M Perel

PMH

PHARM

ECP

CMN

Matthew V. Rudorfer United States

L. F. Gram Denmark

Paul J. Goodnick United States

R R Fieve United States

L.P. Chandler United States

Martin Birkett United States

M. Ansseau Belgium

J. Craig Nelson United States

F M Quitkin United States

Brian Davies Australia

Matthew V. Rudorfer United States

J M Perel

826 ×1.2

PMH

639 ×1.0

PHARM

349 ×0.9

198 ×0.6

ECP

404 ×1.7

CMN

Citations per year, relative to J M Perel J M Perel (= 1×) peers Matthew V. Rudorfer

Countries citing papers authored by J M Perel

Since Specialization

Citations

This map shows the geographic impact of J M Perel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J M Perel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J M Perel more than expected).

Fields of papers citing papers by J M Perel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J M Perel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J M Perel. The network helps show where J M Perel may publish in the future.

Co-authorship network of co-authors of J M Perel

This figure shows the co-authorship network connecting the top 25 collaborators of J M Perel. A scholar is included among the top collaborators of J M Perel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J M Perel. J M Perel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bogen, Debra L., J M Perel, Joseph C. Helsel, et al.. (2012). Pharmacologic evidence to support clinical decision making for peripartum methadone treatment. Psychopharmacology. 225(2). 441–451. 31 indexed citations

Pan, Lisa, Suneeta Madan‐Khetarpal, Michael A. McGuire, et al.. (2011). GTP-cyclohydrolase deficiency responsive to sapropterin and 5-HTP supplementation: relief of treatment-refractory depression and suicidal behaviour: Figure 1. BMJ Case Reports. 2011. bcr0320113927–bcr0320113927. 19 indexed citations

Perel, J M, et al.. (2004). A comparison of d,l-fenfluramine and citalopram challenges in healthy adults. Psychopharmacology. 174(3). 376–80. 18 indexed citations

Perel, J M, et al.. (1998). Gauging the Effectiveness of Extended Imipramine Treatment for Panic Disorder with Agoraphobia. Biological Psychiatry. 43(11). 848–854. 33 indexed citations

Perel, J M, et al.. (1996). Chirality and TDM of Fluoxetine (FL), Norfluoxetine (NFL) and Citalopram (Cit). Clinical Pharmacology & Therapeutics. 59(2). 213–213. 2 indexed citations

Reynolds, Charles F., Ellen Frank, J M Perel, et al.. (1996). High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. American Journal of Psychiatry. 153(11). 1418–1422. 54 indexed citations

Cornelius, Jack R., Ihsan M. Salloum, Marie D. Cornelius, et al.. (1993). Fluoxetine trial in suicidal depressed alcoholics.. PubMed. 29(2). 195–9. 51 indexed citations

Mavissakalian, M & J M Perel. (1992). Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia. American Journal of Psychiatry. 149(8). 1053–1057. 22 indexed citations

Reynolds, Charles F., Ellen Frank, J M Perel, et al.. (1992). Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. American Journal of Psychiatry. 149(12). 1687–1692. 114 indexed citations

10.

Somogyi, George T. & J M Perel. (1991). Biphasic effect of tricyclic antidepressants on the release of norepinephrine from the adrenergic nerves of the rabbit heart. Psychopharmacology. 104(2). 237–243. 5 indexed citations

11.

Pollock, Bruce G., et al.. (1991). S-mephenytoin 4-hydroxylation in older Americans. European Journal of Clinical Pharmacology. 40(6). 609–611. 25 indexed citations

12.

Pollock, Bruce G., J M Perel, & Charles F. Reynolds. (1990). Pharmacodynamic Issues Relevant to Geriatric Psychopharmacology. Journal of Geriatric Psychiatry and Neurology. 3(4). 221–228. 12 indexed citations

13.

Pollock, Bruce G. & J M Perel. (1989). Hydroxy Metabolites of Tricyclic Antidepressants: Evaluation of Relative Cardiotoxicity. PubMed. 7. 232–236. 16 indexed citations

14.

Somogyi, George T. & J M Perel. (1989). Antagonism by tricyclic antidepressants of the muscarinic receptors located on the adrenergic nerve endings in rabbit heart atrium.. Journal of Pharmacology and Experimental Therapeutics. 251(3). 922–928. 6 indexed citations

15.

Mavissakalian, M, et al.. (1987). Trazodone in the treatment of panic disorder and agoraphobia with panic attacks. American Journal of Psychiatry. 144(6). 785–787. 30 indexed citations

16.

Dayton, Peter G., Richard L. Stiller, D. Ryan Cook, & J M Perel. (1983). The binding of ketamine to plasma proteins: Emphasis on human plasma. European Journal of Clinical Pharmacology. 24(6). 825–831. 71 indexed citations

17.

Stiller, Richard L., Peter G. Dayton, J M Perel, & Carl C. Hug. (1982). Gas chromatographic analysis of ketamine and norketamine in plasma and urine: Nitrogen-sensitive detection. Journal of Chromatography B Biomedical Sciences and Applications. 232(2). 305–314. 16 indexed citations

18.

Cunningham, Robert F., J M Perel, Zafar H. Israili, & Peter G. Dayton. (1977). Probenecid metabolism in vitro with rat, mouse, and human liver preparations. Studies of factors affecting the site of oxidation.. Drug Metabolism and Disposition. 5(2). 205–210. 4 indexed citations

19.

Faraj, Bahjat A., Zafar H. Israili, J M Perel, et al.. (1974). METABOLISM AND DISPOSITION OF METHYLPHENIDATE-14C: STUDIES IN MAN AND ANIMALS. Journal of Pharmacology and Experimental Therapeutics. 191(3). 535–547. 142 indexed citations

20.

Israili, Zafar H., J M Perel, Robert F. Cunningham, et al.. (1972). Metabolites of probenecid. Chemical, physical, and pharmacological studies. Journal of Medicinal Chemistry. 15(7). 709–713. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact